Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2
- 1 July 2015
- journal article
- clinical trial
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 7 (294), 294ra105
- https://doi.org/10.1126/scitranslmed.aab2354
Abstract
Similarity between influenza nucleoprotein and hypocretin receptor 2 may trigger vaccine-associated narcolepsy.Keywords
Funding Information
- National Center for Research Resources (S10RR027425)
This publication has 72 references indexed in Scilit:
- HLA dosage effect in narcolepsy with cataplexyImmunogenetics, 2014
- Risk of Narcolepsy Associated with Inactivated Adjuvanted (AS03) A/H1N1 (2009) Pandemic Influenza Vaccine in QuebecPLOS ONE, 2014
- The roles of influenza virus antigens and the AS03 adjuvant in the 2009 pandemic vaccine associated with narcolepsy needs further investigationDevelopmental Medicine and Child Neurology, 2014
- Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in EnglandDevelopmental Medicine and Child Neurology, 2014
- Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: What is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvantsJournal of Autoimmunity, 2014
- Is the adjuvant solely to blame?BMJ, 2013
- Increased Incidence and Clinical Picture of Childhood Narcolepsy following the 2009 H1N1 Pandemic Vaccination Campaign in FinlandPLOS ONE, 2012
- MF59® Adjuvanted Seasonal and Pandemic Influenza VaccinesYAKUGAKU ZASSHI, 2011
- Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in chinaAnnals of Neurology, 2011
- Hypocretin (orexin) deficiency in human narcolepsyThe Lancet, 2000